Results 81 to 90 of about 176,389 (357)

The Role of the Dietitian in Incretin-Based Obesity Therapies in Italy: Practical Clinical Challenges, Professional Clarity, and the Sarcopenic Obesity Perspective

Dietetics
Background: Incretin-based therapies, including glucagon-like peptide-1 (GLP-1) receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor co-agonists, advance obesity treatment by promoting weight loss and lowering the ...
Daniela Ojeda-Mercado, Maurizio Fadda, Benedetta Beltrame, Martina Tosi, Amalia Bruno, Carmen Di Scala, Giancarlo Travaglia, Assunta Vitale, Rita Schiano di Cola, Stefano Boschetti, Federica Pessina, Roberta Jaccheri, Liisa Tolvanen   +12 more
doaj   +1 more source

FIB-4 and BARD scores are efficient markers of HCC risk in non cirrhotic NAFLD and S-MAFLD patients

, 2022
openGli score FIB-4 e BARD sono efficienti nell'individuare il rischio di HCC in pazienti affetti da NAFLD e S ...
D'ANDRIA, GAIA
core  

Logistic regression analysis (non-NAFLD vs NAFLD).

, 2023
Logistic regression analysis (non-NAFLD vs NAFLD).
Jung-Eun Oh (16612224), Nam Hun Heo (9047670), Hyun Joe (16612221), Yong-Jin Cho (5461211), Jangwon Choi (16612218), Hwang-Sik Shin (16612227)   +5 more
core   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

TP53 R249S mutation in hepatic organoids captures the predisposing cancer risk

Hepatology, EarlyView., 2022
The systematic approach in elucidating the gain‐of‐function (GOF) roles of TP53 mutations in early liver carcinogenesis. Unique downstream targets of TP53 L3 mutations were identified from chormatin immunoprecipitation sequencing in HCC cell lines, followed by a series of validation assays to substantiate the exclusive transcriptional regulations ...
Yin Kau Lam, Jianqing Yu, Hao Huang, Xiaofan Ding, Alissa M. Wong, Howard H. Leung, Anthony W. Chan, Kelvin K. Ng, Mingjing Xu, Xin Wang, Nathalie Wong   +10 more
wiley   +1 more source

THE PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN OUTPATIENTS IN THE FAR EAST FEDERAL DISTRICT

Фармакоэкономика, 2017
The rapidly growing incidence of obesity and diabetes mellitus, especially in developed countries, stimulates medical experts to closely study the epidemiology of non-alcoholic fatty liver disease (NAFLD).
V. A. Nevzorova, M. V. Mokshina, T. A. Brodskaya, D. A. Vasil’chenkov, D. V. Blinov, T. I. Ushakova   +5 more
doaj   +1 more source

Serotonergic signaling as a pharmacological target for the treatment of NAFLD

, 2022
reservedLa steatosi epatica non alcolica (NAFLD) è una delle patologie epatiche più diffuse al mondo ed è caratterizzata da un eccessivo accumulo di acidi grassi a livello degli epatociti.
MARCHIOTTO, ANNA
core  

Bifidobacterium Pseudolongum‐Derived Inosine Mitigates Polystyrene Nanoplastics‐Induced Hepatic Injury by Inhibiting the Polarization of M1 Macrophages

Advanced Science, EarlyView.
Probiotic B.p colonization elevated gut‐derived inosine level in the liver, while elevated inosine activated A2AR and subsequently blocked NPs‐induced polarization of M1 macrophages by repressing the miR155/SOCS1/NF‐κB pathway. This reduced the release of inflammatory cytokines and thereby, mitigated NPs‐induced hepatic injury.
Kaikai Zhang, Yuchuan Chen, Jiayuan Wan, Jianzheng Yang, Lijian Chen, Qingyuan Li, Anding Zhou, Nian Zhou, Jiuyang Ding, Qi Wang, Jian Sun   +10 more
wiley   +1 more source

Noninvasive tests for nonalcoholic fatty liver disease in a multi‐ethnic population: The HELIUS study

Hepatology Communications, EarlyView., 2022
Abstract Nonalcoholic fatty liver disease (NAFLD) is increasing in prevalence and severity globally, prompting noninvasive testing, yet limited data exist on noninvasive liver tests (NITs) including transient elastography (TE) in ethnically diverse populations.
Anne‐Marieke van Dijk, Yasaman Vali, Anne Linde Mak, Henrike Galenkamp, Max Nieuwdorp, Bert‐Jan van den Born, Adriaan Georgius Holleboom   +6 more
wiley   +1 more source

Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD)-1

, 2011
Oup (n = 10) at SNP rs2290602 (p = 0.0454).Copyright information:Taken from "Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD)"http://www.biomedcentral.com/1471-230X/8/27BMC Gastroenterology 2008;8()
Hironori Mawatari (94243), Kunihiro Hosono (94246), Hirokazu Takahashi (94249), Shiro Maeyama (94256), Shingo Kato (94245), Noritoshi Kobayashi (94251), Yuichi Nozaki (94240), Masahiko Inamori (94252), Yasunobu Abe (94253), Kikuko Hotta (94239), Hiroshi Iida (94244), Kyoko Yoneda (94248), Hiroki Endo (94241), Takashi Uchiyama (94242), Koichiro Wada (94257), Masato Yoneda (94238), Kensuke Kubota (94254), Koji Fujita (94247), Satoru Saito (94255), Atsushi Nakajima (94258), Hiroyuki Kirikoshi (94250)   +20 more
core   +1 more source